New Study Shows Humira Affectively Treats Psoriasis

The Biological drug Humira which is traditionally used to treat rheumatoid arthritis has recently been shown to affectively combat Psoriasis. According to Biologicaldrugreport.com, “This is the second Phase III study to show positive results for Humira, a biologic currently approved for treatment of rheumatoid arthritis, and Abbott Laboratories said it intends to file during the first half of this year for U.S. and European regulatory approval for Humira in psoriasis. Two other biologics used to treat rheumatoid arthritis, Amgen Inc.'s Enbrel and Centocor's Remicade, have already received FDA approval for treating psoriasis.” In the recent study, 1200 patients plagued with moderate to severe psoriasis were randomly given doses of Humira every other week or receiv View the rest of this article